openPR Logo
Press release

Parkinson`s Disease: 4th Annual New Hope Conference

10-22-2010 07:40 AM CET | Health & Medicine

Press release from: Parkinson Research Foundation

PARKINSON’S DISEASE: NEW HOPE

Fourth Annual PRF Parkinson’s Disease Conference

Deerfield Beach Hilton– Boca Raton, Florida

Monday, November 1, 2010

Program chair, Dr. Stuart Isaacson, M.D.

The Parkinson Research Foundation will be presenting a conference to provide Parkinson’s disease patients and caregivers in Southern Florida with an opportunity to learn about the latest drugs and treatments for Parkinson’s disease that can enhance their lives. A secondary objective is to provide a forum for patients and caregivers to share their concerns and successes with Parkinson’s experts and other local patients.

This 1-day program will have general session presentations throughout the day, exhibition sessions during the sponsored snack breaks, and a question and answer session at the end of every participants and speakers sessions.

Topics to be discussed at the conference include:

• Non-motor Symptoms of Parkinson’s Disease
• Intro to Wii as a Therapy Aid
• Treating Parkinson’s disease, l-dopa to stem cells
• Future Hope for Parkinson’s Disease
• Use It or Lose It
• Advances in Surgery for Parkinson’s Disease
• Voice Aerobics
• Nutrition and Parkinson’s Disease
• How do Support Groups Help

About the Parkinson Research Foundation (PRF)

The Parkinson Research Foundation is a nonprofit health organization providing Parkinson's disease research, information and advocacy. The mission of PRF is to help cure Parkinson's disease and to improve the lives of all people affected by the disease. To fulfill this mission, the Parkinson Research Foundation will fund research, publish scientific findings, provide funding for information and other services to people with Parkinson's disease, their families, caregivers, health care professionals and the public. PRF also expects to be actively involved in advocating for scientific research and for the rights of people with Parkinson's disease.
The money raised by PRF funds research, information programs, and advocacy and awareness efforts that will support the over one million people with Parkinson's disease in communities across America.
For more information about PRF or to register for this November 01, 2010 Conference, please contact Ms. Rosa Seminario at rseminario@parkinsonresearchfoundation.org or call (800) 869-1551 ext. 0. Thank you for your interest and support.

The Parkinson Research Foundation is a nonprofit health organization providing Parkinson's disease research, information and advocacy. The mission of PRF is to help cure Parkinson's disease and to improve the lives of all people affected by the disease. To fulfill this mission, the Parkinson Research Foundation will fund research, publish scientific findings, provide funding for information and other services to people with Parkinson's disease, their families, caregivers, health care professionals and the public. PRF also expects to be actively involved in advocating for scientific research and for the rights of people with Parkinson's disease.

Parkinson Research Foundation
P.O.Box 20256
Sarasota, FL 34238

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson`s Disease: 4th Annual New Hope Conference here

News-ID: 148868 • Views:

More Releases from Parkinson Research Foundation

PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services and Advocacy
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when
PRF PARKINSON’S DISEASE: TREATMENTS OF THE FUTURE
PRF PARKINSON’S DISEASE: TREATMENTS OF THE FUTURE
SIXTH ANNUAL PRF PARKINSON’S DISEASE CONFERENCE Tampa Westshore Marriott Tampa, Florida Monday, March 26, 2012 Program chair, Dr. Juan Sanchez-Ramos The Parkinson Research Foundation will be presenting a conference to provide Parkinson’s disease patients and caregivers in Southwest Florida with an opportunity to learn about the latest drugs and treatments for Parkinson’s disease that will enhance their lives. A secondary objective is to provide a forum for patients and caregivers to share their
Parkinson Research Foundation PRF Encourages Patients To Attend Upcoming Cruise …
PRF is hosting its fourth educational cruise from January 8 – 15, 2012. Cruisers will set sail out of Port Canaveral, Florida on Royal Caribbean’s Freedom of the Seas to embark on a seven-night Western Caribbean adventure. The Parkinson Research Foundation (PRF) developed an educational cruise program to help Parkinson patients, caregivers and their loved ones learn about Parkinson’s and connect with fellow patients from across the world. Each PRF
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutics Market 2021 | Detailed Report
Global Parkinson’s Disease Therapeutics Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,